摘要
The concept of personalized medicine is based upon using personal genetic information to predict individual responses to drug therapy. However, environmental factors such as diet, energy status, gut microbiota, health status and age will influence the expression of one's genetic potential. Metabolomics data from biofluid and tissue sample analysis hold information regarding a patient's genotype and phenotype. Metabolomics data can be rapidly collected from biofluid samples over time, providing temporal metabolic analyses of patient samples. in addition to metabolic markers of a patient's phenotype, metabolomics can provide markers of drug efficacy, toxicity and clearance.
学科与关键词
关键词
biomarkersgeneticsgenomicsmetabolomicspersonalized medicine
- Metabolomics toward personalized medicineJacob, Minnie; Lopata, Andreas L.; Dasouki, Majed; Rahman, Anas M. Abdel*Mass Spectrometry Reviews, 2019, 38(3): 221-238.被引 236
- Integration of pharmacometabolomics with pharmacokinetics and pharmacodynamics: towards personalized drug therapyKantae, Vasudev; Krekels, Elke H. J.; Van Esdonk, Michiel J.; Lindenburg, Peter; Harms, Amy C.; Knibbe, Catherijne A. J.; Van der Graaf, Piet H.; Hankemeier, Thomas*Metabolomics, 2017, 13(1): 9.被引 64
- The promise of metabolic phenotyping in gastroenterology and hepatologyHolmes, Elaine; Wijeyesekera, Anisha; Taylor-Robinson, Simon D.; Nicholson, Jeremy K.*Nature Reviews. Gastroenterology and Hepatology, 2015, 12(8): 458-471.被引 61
